iShares Nasdaq Biotechnology ETF (IBB)

106.98
BATS BZX Real-Time Price
As of 11:49am ET
 -0.82 / -0.76%
Today’s Change
94.20
Today|||52-Week Range
119.30
+0.20%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.

Performance

1 month+0.36% 3 years-3.36%
3 months-2.36% 5 years+12.36%
1 year+10.72% Since inception+7.18%
Data through 05/19/2018

Quote Details

Previous close$107.80
Open day’s range106.51 – 108.42
Net asset value (NAV)107.77 (05/18/2018)
Daily volume90,150
Average volume (3 months)2,915,065
Data as of 11:49am ET, 05/21/2018

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+12.36%+14.29%
Expense Gross exp ratio0.47%1.29%
Risk 5 year sharpe ratio0.630.89
Net assets$8.5B$2.9B
Average market cap$15.1B$9.8B
Average P/E28.122.0
Dividend / Share--0.30%

Competitors

FHLC Fidelity® MSCI Health Care Index ETF
XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene8.31%
AMGN Amgen7.89%
BIIB Biogen7.87%
GILD Gilead Sciences7.62%
VRTX Vertex Pharmaceuticals Inc5.38%
ILMN Illumina Inc4.39%
REGN Regeneron Pharmaceuticals3.94%
ALXN Alexion Pharmaceuticals Inc3.67%
MYL Mylan NV2.93%
BMRN Biomarin Pharmaceutical Inc2.07%